-
Something wrong with this record ?
Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14)
T. Jelinek, J. Mihalyova, M. Kascak, J. Duras, T. Popkova, K. Benkova, P. Richterova, H. Plonkova, J. Zuchnicka, L. Broskevicova, L. Huvarova, L. Cerna, K. Growkova, M. Simicek, M. Havel, J. Gumulec, M. Navratil, Z. Koristek, B. Paiva, R. Hajek,
Language English Country United States
Document type Letter, Research Support, Non-U.S. Gov't
Grant support
No.C.Z.02.1.01/0.0/0.0/17_049/0008440
European Regional Development Fund - International
SGS01/LF201-2019
Ministerstvo Školství, Mládeže a Tělovýchovy - International
SGS01/LF2018-2019
Ministry of Education, Youth and Sports - International
C.Z.02.1.01/0.0/0.0/17_049/0008440
ERDF - International
NLK
Free Medical Journals
from 1998 to 1 year ago
Wiley Free Content
from 1996 to 1 year ago
PubMed
30370955
DOI
10.1002/ajh.25331
Knihovny.cz E-resources
- MeSH
- Bridged Bicyclo Compounds, Heterocyclic pharmacology therapeutic use MeSH
- Bortezomib administration & dosage MeSH
- Molecular Targeted Therapy * MeSH
- Cyclophosphamide administration & dosage MeSH
- Dexamethasone administration & dosage MeSH
- Doxorubicin administration & dosage MeSH
- Combined Modality Therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Chromosomes, Human, Pair 11 genetics MeSH
- Chromosomes, Human, Pair 14 genetics MeSH
- Neoplasm Proteins antagonists & inhibitors MeSH
- Leukemia, Plasma Cell complications drug therapy genetics therapy MeSH
- Antineoplastic Agents pharmacology therapeutic use MeSH
- Antineoplastic Combined Chemotherapy Protocols administration & dosage therapeutic use MeSH
- Proto-Oncogene Proteins c-bcl-2 antagonists & inhibitors MeSH
- Recurrence MeSH
- Neoplasm, Residual MeSH
- Sulfonamides pharmacology therapeutic use MeSH
- Translocation, Genetic MeSH
- Hematopoietic Stem Cell Transplantation MeSH
- Vincristine administration & dosage MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
Centro de Investigación Médica Aplicada Clínica Universidad de Navarra IDISNA Pamplona Spain
Department of Haematooncology University Hospital Ostrava Ostrava Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045169
- 003
- CZ-PrNML
- 005
- 20220104132202.0
- 007
- ta
- 008
- 200109s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/ajh.25331 $2 doi
- 035 __
- $a (PubMed)30370955
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jelinek, Tomas $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Faculty of Science, University of Ostrava, Ostrava, Czech Republic. Centro de Investigación Médica Aplicada, Clínica Universidad de Navarra, IDISNA, Pamplona, Spain.
- 245 10
- $a Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14) / $c T. Jelinek, J. Mihalyova, M. Kascak, J. Duras, T. Popkova, K. Benkova, P. Richterova, H. Plonkova, J. Zuchnicka, L. Broskevicova, L. Huvarova, L. Cerna, K. Growkova, M. Simicek, M. Havel, J. Gumulec, M. Navratil, Z. Koristek, B. Paiva, R. Hajek,
- 650 _2
- $a protinádorové látky $x farmakologie $x terapeutické užití $7 D000970
- 650 _2
- $a protokoly protinádorové kombinované chemoterapie $x aplikace a dávkování $x terapeutické užití $7 D000971
- 650 _2
- $a bortezomib $x aplikace a dávkování $7 D000069286
- 650 _2
- $a bicyklické sloučeniny heterocyklické $x farmakologie $x terapeutické užití $7 D019086
- 650 _2
- $a lidské chromozomy, pár 11 $x genetika $7 D002880
- 650 _2
- $a lidské chromozomy, pár 14 $x genetika $7 D002883
- 650 _2
- $a kombinovaná terapie $7 D003131
- 650 _2
- $a cyklofosfamid $x aplikace a dávkování $7 D003520
- 650 _2
- $a dexamethason $x aplikace a dávkování $7 D003907
- 650 _2
- $a doxorubicin $x aplikace a dávkování $7 D004317
- 650 _2
- $a transplantace hematopoetických kmenových buněk $7 D018380
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a plazmocelulární leukemie $x komplikace $x farmakoterapie $x genetika $x terapie $7 D007952
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a cílená molekulární terapie $7 D058990
- 650 _2
- $a nádorové proteiny $x antagonisté a inhibitory $7 D009363
- 650 _2
- $a reziduální nádor $7 D018365
- 650 _2
- $a protoonkogenní proteiny c-bcl-2 $x antagonisté a inhibitory $7 D019253
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a sulfonamidy $x farmakologie $x terapeutické užití $7 D013449
- 650 _2
- $a translokace genetická $7 D014178
- 650 _2
- $a vinkristin $x aplikace a dávkování $7 D014750
- 655 _2
- $a dopisy $7 D016422
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mihalyova, Jana $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Kascak, Michal $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Duras, Juraj $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Popkova, Tereza $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Benková, Kateřina $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. $7 xx0268009
- 700 1_
- $a Richterova, Petra $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Plonkova, Hana $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Zuchnicka, Jana $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Broskevicova, Lucie $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Huvarova, Lucie $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Faculty of Science, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Cerna, Lucie $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Growkova, Katerina $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Faculty of Science, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Simicek, Michal $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Faculty of Science, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Havel, Martin $u Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Department of Imaging Methods, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Gumulec, Jaromir $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Navratil, Milan $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Koristek, Zdenek $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Paiva, Bruno $u Centro de Investigación Médica Aplicada, Clínica Universidad de Navarra, IDISNA, Pamplona, Spain.
- 700 1_
- $a Hajek, Roman $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- 773 0_
- $w MED00000251 $t American journal of hematology $x 1096-8652 $g Roč. 94, č. 1 (2019), s. E35-E37
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30370955 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20220104132158 $b ABA008
- 999 __
- $a ok $b bmc $g 1483438 $s 1083842
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 94 $c 1 $d E35-E37 $e 20181125 $i 1096-8652 $m American journal of hematology $n Am J Hematol $x MED00000251
- GRA __
- $a No.C.Z.02.1.01/0.0/0.0/17_049/0008440 $p European Regional Development Fund $2 International
- GRA __
- $a SGS01/LF201-2019 $p Ministerstvo Školství, Mládeže a Tělovýchovy $2 International
- GRA __
- $a SGS01/LF2018-2019 $p Ministry of Education, Youth and Sports $2 International
- GRA __
- $a C.Z.02.1.01/0.0/0.0/17_049/0008440 $p ERDF $2 International
- LZP __
- $a Pubmed-20200109